Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP988521.RA3YmWk7bUj9OUJ4-rzCKiKteEdQdvTmHQgxAOYKJPgZU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP988521.RA3YmWk7bUj9OUJ4-rzCKiKteEdQdvTmHQgxAOYKJPgZU130_assertion type Assertion NP988521.RA3YmWk7bUj9OUJ4-rzCKiKteEdQdvTmHQgxAOYKJPgZU130_head.
- NP988521.RA3YmWk7bUj9OUJ4-rzCKiKteEdQdvTmHQgxAOYKJPgZU130_assertion description "[Among the 124 antibiotic-treated patients, 53% with culture-proven erythema migrans (EM) had IgG responses to recombinant glutathione S-transferase (GST)-Arp, as did 59% of the patients with facial palsy and 68% of those with Lyme arthritis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP988521.RA3YmWk7bUj9OUJ4-rzCKiKteEdQdvTmHQgxAOYKJPgZU130_provenance.
- NP988521.RA3YmWk7bUj9OUJ4-rzCKiKteEdQdvTmHQgxAOYKJPgZU130_assertion evidence source_evidence_literature NP988521.RA3YmWk7bUj9OUJ4-rzCKiKteEdQdvTmHQgxAOYKJPgZU130_provenance.
- NP988521.RA3YmWk7bUj9OUJ4-rzCKiKteEdQdvTmHQgxAOYKJPgZU130_assertion SIO_000772 15845501 NP988521.RA3YmWk7bUj9OUJ4-rzCKiKteEdQdvTmHQgxAOYKJPgZU130_provenance.
- NP988521.RA3YmWk7bUj9OUJ4-rzCKiKteEdQdvTmHQgxAOYKJPgZU130_assertion wasDerivedFrom befree-20150227 NP988521.RA3YmWk7bUj9OUJ4-rzCKiKteEdQdvTmHQgxAOYKJPgZU130_provenance.
- NP988521.RA3YmWk7bUj9OUJ4-rzCKiKteEdQdvTmHQgxAOYKJPgZU130_assertion wasGeneratedBy ECO_0000203 NP988521.RA3YmWk7bUj9OUJ4-rzCKiKteEdQdvTmHQgxAOYKJPgZU130_provenance.